The TruVision Advantage
TVCRP is the leader in innovation & execution of comprehensive patient recruitment and clinical trials management.
By combining innovative technology, unmatched expertise, and an unwavering commitment to diversity, we deliver clinical trial success that transforms lies and advances medical science.

Our Clinical Research Consortium Accelerates Trials
TruVision Clinical Research Partners, a Clinical Research Consortium, is a strategic alliance of clinical sites, contract research organizations (CROs), and industry sponsors—working together to transform how clinical trials are designed and executed.
A core pillar of our consortium is our Decentralized Clinical Trial (DCT) capability, which empowers sites and sponsors to reach broader, more diverse patient populations. This unique partnership positions us to help you save more lives, in less time and with lower cost.
Together, we are re-defining what’s possible in clinical research.
We Are A Clinical Research Consortium to Accelerate Trials

TruVision Clinical Research Partners, a Clinical Research Consortium, is a strategic alliance of clinical sites, contract research organizations (CROs), and industry sponsors—working together to transform how clinical trials are designed and executed.
A core pillar of our consortium is our Decentralized Clinical Trial (DCT) capability, which empowers sites and sponsors to reach broader, more diverse patient populations. This unique partnership positions us to help you save more lives, in less time and with lower cost.
Together, we are re-defining what’s possible in clinical research.
PATIENT SUPPORT
TVCRP provides comprehensive support services to enhance the likelihood of the success of clinical trials in all domains.

-
Telehealth
Telehealth enhances patient engagement and data accuracy.
-
Support Services
Continuous support is provided to the patients throughout the trial, including (if necessary) personalized in-home visits, telehealth consultations, and real-time monitoring of patients performing CT tasks.
-
Patient Support
TVCRP has access to a Patient Care Center that is the
central hub for remote monitoring of the CT process. -
Questions
For more information about clinical trials, visit www.clinicaltrials.gov.
Why Choose To Partner with TruVision Clinical Research
TVCRP Leadership

-
Multidisciplinary
ExpertiseThe leadership team of TruVision Clinical Research Partners possesses a wide range of skills and knowledge across various fields including clinical trials (PI, CRO and EDC), healthcare technology, pharmacology, community engagement, regulatory affairs, Ai & machine learning, and patient support.
This multidisciplinary expertise is essential for the success for the "execution in all domains" approach of clinical trials by TruVision Clinical Research Partners.
-
Commitment to Inclusivity & Innovation
The TVCRP team's dedication to inclusivity, mitigation of the impacts of SODH, innovation and commitment to high standards of clinical practice enables TVCRP to effectively address inclusion of underrepresented populations in clinical trials. It also allows TVCRP to integrate advanced technologies and provide comprehensive support to its principal investigators (sub investigators) and patients, ultimately improving health outcomes for diverse populations.
Our Leadership Team
TVCRP's leadership team reflects the community it serves by having multidisciplinary professionals including medical, technology, and entrepreneurs with lived experience that informs a culturally competent approach to clinical trial design, execution and patient recruitment.

Brian A. Stone MD, FACS

Lydell Lettson MD, FACS

Lenore Coleman, PharmD

Richard Walker, MD, MBA

David Warsing

Montenia Edwards MPH

Vincent Akinola MD

Kimberly Kelly, Phd, CRNP

Chris Melson

Nadav Lankin
Expertise That Drives Results
Collective Clinical Trials Experience Summary
- Advanced Ocular Melanoma – Phase 2, multi-country
- Ophthalmology (Device) Myopia Study – Phase 3 Single country
- Ophthalmology (Device) Myopia Post-marketing – Phase 4
- Single Country Ophthalmology Cataract Study – Phase 3 Multi-Country
- Cervical Intraepithelial Neoplasia – Phase 1/2a, multi-country
- Metastatic Squamous Non-small cell Lung Cancer – Phase 3 Multi-country
- Metastatic Non-squamous Non-Small Cell Lung Cancer – Phase 3, multi-country
- Brain metastases from Non-small cell Lung Cancer – Phase 3 Multi-country
- Peripheral T-cell Lymphoma – Phase 2 Single Country
- Breast Cancer/Bone Pain – Phase 2b Multi-Country
- B-Cell Lymphoma – Phase 3 multi country
- Pancreatic Cancer – Phase 3 multi-country
- SARs CoV2 (Covid-19) – Phase 2, single country
- SARS CoV2 (COVID-19) – Observational Study, Single Country
- Influenza Study – Phase 3, single country
Crohn’s Disease – Phase 3 Multi-Country
- Angina – Phase 3, multi country
- Atrial Fibrillation – Pilot Study, Single Center
- Atherosclerosis Study – Phase 2 Multi-Center
- Vertis CV-Diabetes Safety Study – Phase 3 Multi-Center
- Chest Pain Study – Phase 3 Multi-Country
- Hypertension Study – Phase 2 Multi-Country
- Type 1 Diabetes Study – Phase 2, Multi-Country
- Type 2 Diabetes Study – Phase 2, Multi-Country
- Urinary Incontinence – Phase 3 Multi-Country
- Overactive Bladder – Phase 3, multi-country
- Prostate cancer – Phase 1, multi-country
- Abarelix Prostate Cancer Study – Phase 3 Multi-Center
- Vardenafil ED Study – Phase 3 Multi-Center
- Lupron Prostate Cancer Study – Phase 3 Multi-Cente
- Uprima ED Study – Phase 3 Multi-Center
- Vasomax ED Study – Phase 3 Multi-Center
Chronic Kidney disease – Phase 3 multi-country
- Anxiety Disorder – Phase 3 Single Country
- Alzheimer’s Study – Phase 2 Multi-Center
- Bipolar 1 Disorder – Phase 1&2, single-country
- Schizophrenia with Ophthalmology Component – Phase 2 Single Country
- Pain Management – Phase 3 Multi-Country
- Major Depressive Disorder Study – Phase 2 Single Country
- Sickle Cell 1st in Human Study – Phase 1 Multi-Center
- Sickle Cell Study – Phase 1 Multi-Center, Multi-Country
- Sickle Cell Study – Phase 2/3 Multi-Country
- COPD Study – Phase 2/3 Multi-Center
- Gout Study – Phase 3 Multi-Country
- Wound Healing Device Study – Phase 2 Multi-Center
- Antibiotic Coated Penile Prosthesis – Phase 3 Multi-Center
- Urinary Incontinence Device Study – Phase 3 Multi-Center
- MIST BPH Study – Prospective Multi-Center Surgical study

Join the Future of Clinical Research
Contact Us Today to explore how TVCRP can partner with you.

Join the Future of Clinical Research
Contact Us Today to explore how TVCRP can partner with you.

About Us
We are the leader in innovation & execution of comprehensive patient recruitment and
clinical trial management.